Concepedia

Publication | Closed Access

Determinants of serious liver disease among patients receiving low‐dose methotrexate for rheumatoid arthritis

DOI

202

Citations

12

References

1993

Year

Alexander M. Walker, Donnie Funch, Nancy A Dreyer, Keith G. Tolman, Joel M. Kremer, Graciela S. Alarcón, Randall G. Lee, Michael E. Weinblatt
Arthritis & Rheumatism

Abstract

Serious liver disease is an uncommon, age- and dose-related complication of low-dose MTX therapy for RA.

References

YearCitations

Page 1